Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: subgroup analysis of a randomized clinical trial
GLP-1 drugs' proven ability to deliver superior glucose control, weight reduction benefits, and cardiovascular protection makes them essential treatments for modern diabetes management and metabolic health applications
IMA Petitions for Restrictive Prescription Rights The Indian Medical Association (IMA) has expressed formal concern regarding the "on-demand" availability of GLP-1 drugs through retail and online platforms
If youre considering GLP-1 therapy, this is also a good time to know that you dont need to be perfectly structured for it to work for you
Trends Neurosci 31(5):234242 Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans
but with results like this, why wouldn't you
